STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 98 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $182,000 | -28.3% | 37,646 | +57.3% | 0.00% | 0.0% |
| Q4 2019 | $254,000 | -33.9% | 23,929 | -19.9% | 0.00% | -66.7% |
| Q1 2019 | $384,000 | -10.9% | 29,864 | -34.2% | 0.01% | -25.0% |
| Q4 2018 | $431,000 | -12.4% | 45,413 | +48.1% | 0.01% | 0.0% |
| Q2 2018 | $492,000 | +154.9% | 30,656 | +148.0% | 0.01% | +166.7% |
| Q4 2017 | $193,000 | +20.6% | 12,360 | -33.9% | 0.00% | 0.0% |
| Q1 2017 | $160,000 | -40.1% | 18,700 | -25.1% | 0.00% | -40.0% |
| Q4 2016 | $267,000 | -51.9% | 24,954 | -51.3% | 0.01% | -50.0% |
| Q3 2016 | $555,000 | +46.8% | 51,243 | -8.3% | 0.01% | +25.0% |
| Q2 2016 | $378,000 | +62.9% | 55,854 | +12.0% | 0.01% | +60.0% |
| Q1 2016 | $232,000 | +46.8% | 49,860 | +272.1% | 0.01% | +66.7% |
| Q2 2015 | $158,000 | – | 13,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 475,200 | $6,877,000 | 3.03% |
| Avoro Capital Advisors LLC | 475,000 | $6,873,000 | 2.64% |
| VHCP Management, LLC | 451,400 | $6,532,000 | 1.50% |
| Sio Capital Management, LLC | 140,000 | $2,026,000 | 1.15% |
| Opus Point Partners Management, LLC | 75,000 | $1,085,000 | 0.91% |
| Eventide Asset Management | 620,200 | $8,974,000 | 0.68% |
| Telemetry Investments, L.L.C. | 55,000 | $796,000 | 0.44% |
| Healthcare Value Capital, LLC | 25,000 | $362,000 | 0.40% |
| TFS CAPITAL LLC | 259,916 | $3,761,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 672,562 | $9,732,000 | 0.14% |